<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Mycobacterium bovis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Mycobacterium bovis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Mycobacterium bovis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elizabeth A Talbot, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">C Fordham von Reyn, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 28, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H26587851"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The <em>Mycobacterium tuberculosis</em> complex includes <em>M. tuberculosis</em> (the cause of most human tuberculosis), <em>M. bovis</em>, <em>M. bovis</em> Bacillus Calmette-Guérin (BCG, the vaccine strain), <em>M. africanum</em>, <em>M. microti,</em> and others [<a href="#rid1">1</a>]. All are gram-positive, aerobic, and acid-fast bacilli. </p><p><em>M. bovis</em> is the main cause of tuberculosis in cattle, deer, and other mammals and shows some features distinct from <em>M. tuberculosis</em> in humans. <em>M. bovis</em> may have transitioned from humans to animals; animal domestication facilitated spread and maintenance in animals [<a href="#rid2">2</a>], although the strains are remarkably related genetically (99.95 percent) [<a href="#rid3">3</a>]. Novel molecular methods such as whole-genome sequencing, mycobacterial interspersed repetitive-unit-variable-number tandem-repeat typing, and spoligotyping are now contributing to improved understanding of evolution and strain features [<a href="#rid4">4</a>].</p><p>The epidemiology, transmission, clinical manifestations, diagnosis, treatment, and prognosis of human <em>M. bovis</em> (referred to as "zoonotic tuberculosis") will be reviewed here. Issues related to the <a class="drug drug_general" data-topicid="102736" href="/d/drug information/102736.html" rel="external">BCG vaccine</a> strain are discussed separately, as are issues related to BCG for treatment of bladder cancer. (See  <a class="medical medical_review" href="/d/html/8022.html" rel="external">"Prevention of tuberculosis: BCG immunization and nutritional supplementation"</a> and  <a class="medical medical_review" href="/d/html/2973.html" rel="external">"Infectious complications of intravesical BCG immunotherapy"</a>.)</p><p class="headingAnchor" id="H26587857"><span class="h1">EPIDEMIOLOGY AND RISK FACTORS</span></p><p class="headingAnchor" id="H488240"><span class="h2">Epidemiology</span></p><p class="headingAnchor" id="H26587864"><span class="h3">Worldwide</span><span class="headingEndMark"> — </span>The burden of zoonotic tuberculosis<em> </em>is underestimated as a cause of tuberculosis in humans, due to the absence of systematic surveillance in countries where bovine tuberculosis is endemic, lack of awareness and expertise among health care providers and because the usual laboratory procedures used to diagnose human tuberculosis do not reliably differentiate <em>M. bovis </em>from <em>M. tuberculosis </em>[<a href="#rid5">5</a>].</p><p>Despite these limitations, the World Health Organization estimates that<em> M. bovis</em> caused 143,000 new cases and 12,300 deaths in 2018 [<a href="#rid6">6</a>]. However, only 16 countries reported within this surveillance effort, which in part explains the broad range for that estimate (71,000 to 240,000). Stated as a proportion, <em>M. bovis</em> caused approximately 1.4 percent of the 10 million incident pulmonary tuberculosis cases globally [<a href="#rid6">6</a>]. Among patients with extrapulmonary tuberculosis, the proportion of <em>M. bovis</em> is higher because human <em>M. bovis</em> infection generally occurs in the setting of consumption of infected cow's milk products, so scrofula (infection of the lymph node[s] in proximity to the mouth and esophagus) and gastrointestinal disease are typical clinical manifestations [<a href="#rid7">7</a>].</p><p>In developed countries where bovine tuberculosis is controlled and dairy products are pasteurized routinely, the proportion of <em>M. bovis</em> infection among human tuberculosis cases is often lower than the global estimate. As an example, in the United Kingdom, <em>M. bovis</em> caused approximately 0.5 percent of culture-confirmed human tuberculosis in 2007 [<a href="#rid8">8</a>] and has been decreasing: between 2005 and 2008, the annual incidence of <em>M. bovis</em> decreased from 0.065 to 0.047 per 100,000 population [<a href="#rid9">9</a>]. In a Spanish hospital, <em>M. bovis</em> caused approximately 0.95 percent of tuberculosis cases between 1980 and 2003 [<a href="#rid10">10</a>]. However, the proportion may be higher among certain at-risk populations; as an example, one retrospective study among HIV-infected patients in France noted that <em>M. bovis</em> infection accounted for 1.6 percent of tuberculosis cases [<a href="#rid11">11</a>].</p><p>In resource-limited settings, reliable and representative national data regarding the relative frequency of human tuberculosis due to <em>M. bovis</em> are limited [<a href="#rid12">12</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>In an analysis of more than 1100 human tuberculosis isolates obtained in Mexico City between 2000 and 2014, <em>M. bovis </em>accounted for 26 percent of isolates (from all sites) and 16 percent of pulmonary samples [<a href="#rid13">13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a systematic review from Nigeria including 17 studies and 1693 mycobacteria isolates obtained between 1975 and 2014, 1.3 percent of the <em>M. tuberculosis</em> isolates were identified in cattle, while 8 percent of the <em>M. bovis</em> isolates were isolated from humans [<a href="#rid14">14</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Among 1599 isolates from acid-fast bacilli-smear positive patients in Ethiopia between 2011 and 2013, molecular typing identified two isolates (0.13 percent) as <em>M. bovis</em> [<a href="#rid15">15</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a Chinese study including three years of data from more than 5000 patients in a region with known <em>M. bovis</em> cattle infection, <em>M. bovis</em> accounted for 0.34 percent of human tuberculosis cases [<a href="#rid16">16</a>]. In a subsequent survey among more than 4000 clinical tuberculosis strains isolated from sputum between 2007 and 2009, none were <em>M. bovis </em>[<a href="#rid17">17</a>].</p><p></p><p class="headingAnchor" id="H26587870"><span class="h3">United States</span><span class="headingEndMark"> — </span>Among 59,273 cases of tuberculosis in the United States between 2006 and 2013, <em>M. bovis</em> accounted for 1.3 to 1.6 percent of cases [<a href="#rid18">18</a>]. In some settings, the proportion is higher and may be increasing.</p><p>As an example, in a retrospective analysis of tuberculosis cases between 1994 and 2005 in San Diego, California, the incidence of <em>M. bovis</em> increased from 0.65 to 0.93 per 100,000 population. Because the overall incidence of <em>M. tuberculosis</em> declined, the annual proportion of culture-positive tuberculosis cases attributable to <em>M. bovis</em> increased from 5 to 11 percent [<a href="#rid19">19</a>]. This was particularly striking among children &lt;15 years of age in whom <em>M. bovis</em> comprised 54 percent of tuberculosis cases [<a href="#rid19">19</a>]. In a study of 86 patients with HIV and tuberculosis coinfection between 2000 and 2007 in southern California, 35 percent had <em>M. bovis</em> infection [<a href="#rid20">20</a>]. A subsequent review of the California tuberculosis registry showed that the percentage of tuberculosis cases attributable to <em>M. bovis</em> increased between 2003 and 2011, from 3.4 to 5.4 percent [<a href="#rid21">21</a>].</p><p class="headingAnchor" id="H488876"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>Among patients diagnosed with tuberculosis, the possibility of <em>M. bovis</em> should be considered in patients who may have consumed unpasteurized dairy products or had contact with infected animals or humans [<a href="#rid22">22</a>]. A systematic review of occupational zoonotic tuberculosis found livestock farmers, veterinarians and their assistants, abattoir workers, hunters, and workers in contact with wildlife at risk [<a href="#rid23">23</a>]. <em>M. bovis</em> should also be considered in the setting of extrapulmonary disease [<a href="#rid20">20,21,24,25</a>], immunosuppression [<a href="#rid20">20,21</a>], <a class="drug drug_general" data-topicid="9836" href="/d/drug information/9836.html" rel="external">pyrazinamide</a> monoresistance [<a href="#rid26">26</a>], Hispanic ethnicity [<a href="#rid19">19,21</a>], and children &lt;15 years of age with tuberculosis [<a href="#rid19">19</a>]. Multivariate analysis of the California tuberculosis registry also identified diabetes as independently associated with <em>M. bovis</em> disease [<a href="#rid21">21</a>]. Among children with <em>M. bovis</em> tuberculosis during 2010 to 2011, all had &gt;1 parent/guardian born in Mexico, compared with 38 percent for children with <em>M. tuberculosis</em>.</p><p>Among 165 patients in the United States with <em>M. bovis</em> who underwent genotyping from 1995 to 2005, 89 percent were Hispanic individuals, 62 percent were born in Mexico, 19 percent were &lt; 15 years old (compared with only 2 percent in those with <em>M. tuberculosis</em>), 65 percent had extrapulmonary disease, and 26 percent were HIV infected [<a href="#rid27">27</a>]. Among 511 patients with tuberculosis in Italy, 1.76 percent were caused by <em>M. bovis.</em> <em>M. bovis</em> was significantly more common among those with extrapulmonary disease and older adults [<a href="#rid28">28</a>]. In a retrospective study including 35 Mexican patients with <em>M. bovis</em> infection, 51 percent were children, 69 percent had malnutrition, 51 percent consumed unpasteurized milk, and 6 percent had contact with animals [<a href="#rid25">25</a>]. Another retrospective study including 39 patients with confirmed <em>M. bovis</em> in Argentina noted strong risk factors included occupational exposure (65 percent), a history of living in a rural area (31 percent), and consumption of unpasteurized milk (4 percent) [<a href="#rid22">22</a>].</p><p>In a retrospective review of 533 Mexican patients with a cultured isolate of <em>M. tuberculosis </em>complex, <em>M. bovis</em> was the cause in 30 percent of cases<em> </em>[<a href="#rid29">29</a>]. Patients with <em>M. bovis</em> were more likely to be younger, using glucocorticoids, and to have extrapulmonary disease. Among the subset of patients with only a pulmonary isolate of <em>M. bovis,</em> smoking was an additional risk factor for <em>M. bovis. </em>There was no difference between <em>M. bovis</em> and <em>M. tuberculosis</em> with regards to the proportion with positive sputum smear or cavitation on chest radiograph.</p><p class="headingAnchor" id="H26587876"><span class="h2">Transmission</span><span class="headingEndMark"> — </span><em>M. bovis</em> may be transmitted from humans to animals, animals to humans, between animals [<a href="#rid30">30</a>], or between humans. People can become infected with <em>M. bovis</em> via oral ingestion, droplet inhalation, or cutaneous penetration [<a href="#rid7">7</a>].</p><p><em>M. bovis</em> has been identified in water and soil samples; it is uncertain whether this may be a source of disease transmission [<a href="#rid7">7</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Animal to human</strong> – <em>M. bovis</em> can be transmitted from animals to humans via ingestion of animal products or via airborne particle inhalation [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cattle</strong> – Humans can become infected with <em>M. bovis</em> via ingestion of infected dairy products (the most common mode of <em>M. bovis</em> infection transmission) [<a href="#rid31">31</a>] or via airborne particle inhalation.</p><p></p><p class="bulletIndent2">In one surveillance study among more than 300 farm workers in Mexico exposed to cattle with <em>M. bovis</em> infection (many of whom consumed unpasteurized milk), more than half of individuals had evidence of latent tuberculosis infection [<a href="#rid31">31</a>]. A positive <a class="drug drug_general" data-topicid="10029" href="/d/drug information/10029.html" rel="external">tuberculin skin test</a> (TST) was observed in 76 percent, and 58 percent had a positive interferon-gamma release assay; this prevalence is higher than other high-risk populations in Mexico, including individuals in border cities (57 percent), migrant workers (26 percent), and health care workers (up to 64 percent). Two cases of active <em>M. bovis</em> infection were identified, one of which matched the prevalent strain found in the cattle.</p><p></p><p class="bulletIndent2">Among 129 cases of human <em>M. bovis</em> infection in the United Kingdom between 2005 and 2008, most patients were older than 65 years, suggesting that reactivation may have occurred following latent infection acquired prior to widespread pasteurization of milk [<a href="#rid9">9</a>]. In another study including 70 livestock traders in Nigeria, 10 percent had sputum culture positive for the <em>M. tuberculosis</em> complex; of these, 28 percent were further identified as <em>M. bovis</em>. Work in the livestock trade for at least three years was a risk factor for infection [<a href="#rid32">32</a>]. A genetic characterization of <em>M. bovis</em> strains in Burkina Faso suggests that <em>M. bovis</em> transmission occurs mainly between cattle within and beyond Burkina Faso, but also occasionally from cattle to humans and potentially between humans [<a href="#rid33">33</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other animals</strong> – Other animal species can transmit <em>M. bovis</em> to humans, although this is less common than transmission from cattle. One report in 1990 noted epizootic <em>M. bovis</em> infection from domesticated elk (<em>Cervus elaphus</em>) in Alberta, Canada. Among 394 humans with animal contact, 22 percent were noted to have positive TSTs, and most were known to have had contact with culture-positive animals [<a href="#rid34">34</a>]. In addition, transmission of M. bovis from deer to hunters in Michigan (where M. bovis is endemic in deer) has been described [<a href="#rid35">35,36</a>]. Rare cat-to-human transmission has also been suggested by a United Kingdom study [<a href="#rid37">37</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Human to human</strong> – Human-to-human transmission of <em>M. bovis</em> infection occurs rarely. Case reports include descriptions of transmission among homeless shelter residents, within households, at a church, and between siblings on a farm in the United Kingdom, and from a Dutch health care worker [<a href="#rid38">38-42</a>]. In one cluster of six cases in the United Kingdom, the source case had prior contact with cattle and consumed unpasteurized dairy products [<a href="#rid40">40</a>]; all subsequent cases were visitors to bars with favorable conditions for transmission (eg, prolonged close contact in a confined space with poor ventilation).</p><p></p><p class="bulletIndent1">Nosocomial transmission of multidrug-resistant <em>M. bovis</em> has also been described [<a href="#rid43">43-46</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Human to animal</strong> – <em>M. bovis</em> can be transmitted from humans to animals presumably through airborne particle inhalation. One such example is described in a report of <em>M. bovis</em> transmission between a human and two indoor-housed pet cats [<a href="#rid47">47</a>].</p><p></p><p class="headingAnchor" id="H3407396844"><span class="h2">Drug resistance</span><span class="headingEndMark"> — </span><em>M. bovis</em> is intrinsically resistant to PZA; apart from PZA resistance, primary and acquired drug resistance has been described [<a href="#rid26">26,43-46</a>]. In a report from Mexico City between 2000 and 2014, <a class="drug drug_general" data-topicid="8577" href="/d/drug information/8577.html" rel="external">isoniazid</a>, <a class="drug drug_general" data-topicid="9864" href="/d/drug information/9864.html" rel="external">rifampin</a>, and <a class="drug drug_general" data-topicid="10238" href="/d/drug information/10238.html" rel="external">streptomycin</a> resistance in previously untreated patients was higher <em>among M. bovis than M. tuberculosis</em> isolates (10.9 versus 3.4 percent) and appeared to be increasing (from 3.4 percent [2000 to 2004] to 7.6 percent [2010 to 2014]). Resistance rates to at least isoniazid and rifampin in patients who were previously treate<em>d for M. bovis and M. tuberculosis</em> were 38.5 percent and 34.4 percent, respectively [<a href="#rid13">13</a>]. </p><p>Data regarding genetic mechanisms for drug resistan<em>ce </em>in<em> M. bovis</em> are emerging [<a href="#rid43">43,48,49</a>]. An analysis including 2074<em> M. bovis</em> isolates recovered from non-human hosts employed whole genome sequencing to identify the most frequent mutations associated with tuberculosis drug resist<em>a</em>nc<em>e</em>;<em> M. bovis</em> isolates were found to harbor the same mutations that confer resistance to both first- and second-line antimycobacterial antibiotics [<a href="#rid50">50</a>].</p><p class="headingAnchor" id="H26587906"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Tuberculosis due to <em>M. bovis</em> is clinically and radiographically indistinguishable from tuberculosis due to <em>M. tuberculosis</em>. Like <em>M. tuberculosis</em>, <em>M. bovis</em> can manifest with primary and reactivation forms; involvement may be pulmonary, extrapulmonary, or disseminated. When <em>M. bovis </em>is acquired via ingestion of contaminated dairy products, extrapulmonary disease is more likely than pulmonary tuberculosis [<a href="#rid20">20,24,25</a>]. Extrapulmonary sites of <em>M. bovis</em> include lymph nodes (scrofula) [<a href="#rid51">51</a>], pleural space [<a href="#rid10">10</a>], joints [<a href="#rid52">52,53</a>], eye [<a href="#rid54">54</a>], the central nervous system [<a href="#rid55">55,56</a>], and abdominal organs [<a href="#rid57">57,58</a>].</p><p>The clinical manifestations, physical examination findings, and radiographic abnormalities of tuberculosis are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/7026.html" rel="external">"Pulmonary tuberculosis: Clinical manifestations and complications"</a>.)</p><p class="headingAnchor" id="H26587912"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The initial diagnostic approach for <em>M. bovis</em> is identical to the diagnostic approach for <em>M. tuberculosis</em>, including acid-fast bacilli staining and mycobacterial culture of relevant specimens, and molecular testing for mycobacterial DNA (such as GeneXpert MTB/RIF)<em> </em>[<a href="#rid59">59</a>]. Both the <a class="drug drug_general" data-topicid="10029" href="/d/drug information/10029.html" rel="external">tuberculin skin test</a> and interferon-gamma release assays can detect <em>M. bovis</em> infection [<a href="#rid60">60</a>]. (See  <a class="medical medical_review" href="/d/html/115049.html" rel="external">"Tuberculosis infection (latent tuberculosis) in adults: Approach to diagnosis (screening)"</a>.)</p><p>The United States Centers for Disease Control and Prevention the National Tuberculosis Genotyping Service which allows differentiation of <em>M. bovis</em> from <em>M. tuberculosis</em> [<a href="#rid61">61</a>]. However, distinguishing <em>M. bovis</em> from other <em>M. tuberculosis</em> complex (MTBC) strains is not done in most laboratories outside the United States. Additional laboratory investigation should be requested when there is epidemiologic risk for <em>M. bovis</em>, failure to respond clinically to initial empiric therapy, or susceptibility testing that demonstrates <a class="drug drug_general" data-topicid="9836" href="/d/drug information/9836.html" rel="external">pyrazinamide</a> (PZA) resistance.</p><p>Identification of PZA monoresistance in an MTBC strain should prompt consideration of <em>M. bovis</em>; however, dependence solely on PZA resistance testing to identify <em>M. bovis</em> is not appropriate because PZA resistance testing is technically difficult and is not performed routinely or reliably in many laboratories. In a United States surveillance study performed between 1995 and 2005, the sensitivity of PZA susceptibility for identification of <em>M. bovis</em> was about 80 percent [<a href="#rid27">27</a>]. A subsequent report including 500 <em>M. bovis</em> isolates noted that 7 percent were incorrectly reported as PZA susceptible [<a href="#rid26">26</a>]. </p><p>For conclusive identification of <em>M. bovis</em>, the isolate should be sent to a public health laboratory or a mycobacterial reference laboratory. Mechanisms for differentiation of <em>M. bovis</em> from <em>M. tuberculosis</em> include biochemical assays (niacin test, heat-sensitive catalase, nitrate reduction), susceptibility to an <a class="drug drug_general" data-topicid="8577" href="/d/drug information/8577.html" rel="external">isoniazid</a> analogue (thiophene-2-carboxylic acid hydrazide; TCH), and genomic analysis [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H714250687"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis for <em>M. bovis</em> pulmonary disease includes:</p><p class="bulletIndent1"><span class="glyph">●</span><em>M. tuberculosis</em> disease – Tuberculosis caused by <em>M. tuberculosis</em> is clinically and radiographically indistinguishable from tuberculosis caused by <em>M. bovis</em>. The diagnosis is established via culture, with additional testing for <em>M. bovis</em> as described above. (See  <a class="medical medical_review" href="/d/html/111683.html" rel="external">"Diagnosis of pulmonary tuberculosis in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nontuberculous mycobacterial infection (NTM) – Symptoms of NTM include fatigue, dyspnea, and occasional hemoptysis; fever and weight loss occur less frequently than in patients with tuberculosis. NTM is distinguished from tuberculosis by culture results and/or molecular diagnostic testing. (See  <a class="medical medical_review" href="/d/html/5342.html" rel="external">"Overview of nontuberculous mycobacterial infections"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fungal infection – Fungal pneumonia can present with a range of manifestations including pneumonia, pulmonary nodule, and cavitary lung disease. It is distinguished from tuberculosis by epidemiologic exposure and culture results. (See  <a class="medical medical_review" href="/d/html/2451.html" rel="external">"Diagnosis and treatment of pulmonary histoplasmosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sarcoidosis – Sarcoidosis most commonly presents with diffuse interstitial lung disease. It rarely forms cavities and is distinguished from tuberculosis by histopathologic detection of noncaseating granulomas. (See  <a class="medical medical_review" href="/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lung cancer – Lung cancer most commonly presents with cough, hemoptysis, chest pain, and dyspnea. It is distinguished from tuberculosis by histopathology. (See  <a class="medical medical_review" href="/d/html/4641.html" rel="external">"Clinical manifestations of lung cancer"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lymphoma – Lymphoma typically presents with a rapidly growing mass together with fever, night sweats, and weight loss. It is distinguished from tuberculosis by histopathology. (See related topics.)</p><p></p><p class="headingAnchor" id="H26587918"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span><em>M. bovis</em> is intrinsically resistant to PZA; therefore, the approach to treatment of disease due to <em>M. bovis</em> is extrapolated from experience with the treatment of <a class="drug drug_general" data-topicid="9836" href="/d/drug information/9836.html" rel="external">pyrazinamide</a> (PZA)-resistant <em>M. tuberculosis</em>.</p><p class="headingAnchor" id="H935714541"><span class="h2">Drug-susceptible disease</span><span class="headingEndMark"> — </span>For patients with disease due to drug-susceptib<em>le M. bovis</em>, treatment consists of two months of <a class="drug drug_general" data-topicid="8577" href="/d/drug information/8577.html" rel="external">isoniazid</a>, <a class="drug drug_general" data-topicid="9864" href="/d/drug information/9864.html" rel="external">rifampin</a>, and <a class="drug drug_general" data-topicid="9430" href="/d/drug information/9430.html" rel="external">ethambutol</a> administered daily, followed by seven months of isoniazid and rifampin [<a href="#rid62">62,63</a>]. The duration of therapy for pulmonary and most extrapulmonary disease should be nine months, although the optimal duration for meningitis has not been established; some experts recommend at least 12 months for such cases [<a href="#rid55">55</a>].</p><p>Data to guide treatment of <em>M. bovis</em> disease are limited:</p><p class="bulletIndent1"><span class="glyph">●</span>A systematic review identified studies reporting two cohorts with 156 patients who received <a class="drug drug_general" data-topicid="8577" href="/d/drug information/8577.html" rel="external">isoniazid</a> and <a class="drug drug_general" data-topicid="9864" href="/d/drug information/9864.html" rel="external">rifampin</a> for 6 to 9 months and two cohorts with 113 patients who received isoniazid, rifampin, and <a class="drug drug_general" data-topicid="9430" href="/d/drug information/9430.html" rel="external">ethambutol</a> for 6 to 12 months. Analysis of outcomes suggests that the efficacy of both regimens is adequate (99 percent and 93 percent with and without EMB, respectively), and that there were inadequate data to support a treatment duration of &lt;9 months [<a href="#rid64">64</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In one study including more than 290 patients with <em>M. bovis</em> (sputum culture-positive; sensitive to <a class="drug drug_general" data-topicid="8577" href="/d/drug information/8577.html" rel="external">isoniazid</a> and <a class="drug drug_general" data-topicid="9864" href="/d/drug information/9864.html" rel="external">rifampin</a>) and more than 30,800 patients with <em>M. tuberculosis </em>(sputum culture-positive; sensitive to PZA, isoniazid, and rifampin) who were treated with initial four-drug therapy between 2006 and 2013, the rate of sputum culture conversion by three months of therapy was similar (85 versus 83 percent); however, more <em>M. bovis </em>patients died during treatment (9 versus 5 percent), suggesting that early culture conversion is not necessarily associated with a favorable clinical outcome [<a href="#rid65">65</a>].</p><p></p><p class="headingAnchor" id="H1517415830"><span class="h2">Drug-resistant disease</span><span class="headingEndMark"> — </span><em>M. bovis</em> is intrinsically resistant to PZA; apart from PZA resistance, primary and acquired drug resistance has been described. (See <a class="local">'Drug resistance'</a> above.)</p><p>For patients with disease to an <em>M. bovis</em> strain that is resistant to drugs (apart from PZA), or for patients who are intolerant of first line drugs, the treatment regimen should be chosen according to susceptibility testing results with expert consultation, similar to the approach for treatment of multidrug-resistant tuberculosis. (See  <a class="medical medical_review" href="/d/html/8028.html" rel="external">"Treatment of drug-resistant pulmonary tuberculosis in adults"</a>.)</p><p class="headingAnchor" id="H26587924"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>The prognosis for tuberculosis due to <em>M. bovis</em> is worse than for disease due to <em>M. tuberculosis </em>[<a href="#rid62">62,65</a>]. In one study including more than 290 patients in the United States with <em>M. bovis</em> and more than 30,800 patients with <em>M. tuberculosis </em>between 2006 and 2013, the rate of death was higher among patients with <em>M. bovis </em>infection (9 versus 5 percent) [<a href="#rid65">65</a>]. In another study including 35 Mexican patients with <em>M. bovis</em>, 31 percent died [<a href="#rid25">25</a>]. In the Netherlands between 2003 and 2011, mortality due to <em>M. bovis</em> was higher than <em>M. tuberculosis</em> (20 versus 4 percent) [<a href="#rid24">24</a>].</p><p>Among patients with HIV infection, the prognosis for <em>M. bovis</em> tuberculosis also appears worse than the prognosis for <em>M. tuberculosis</em>. One cohort including 86 HIV-infected patients with tuberculosis in the San Diego, California, area noted a mortality rate of 10 percent (versus 3.6 percent with <em>M. tuberculosis</em>) [<a href="#rid20">20</a>]. In another report including 19 HIV-infected patients with primary multidrug-resistant <em>M. bovis</em>, all patients died [<a href="#rid46">46</a>].</p><p>These observations may be due to delay in recognition of <em>M. bovis</em> infection, insufficient duration of treatment in the setting of <a class="drug drug_general" data-topicid="9836" href="/d/drug information/9836.html" rel="external">pyrazinamide</a> resistance, older patient age (due to reactivation disease following remote cattle exposure), or increased virulence of <em>M. bovis</em>.</p><p class="headingAnchor" id="H26587930"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>A roadmap to reduce zoonotic tuberculosis was developed by the World Health Organization, the World Organization for Animal Health, and the Food and Agricultural Organization of the United Nations, and the International Union Against Tuberculosis and Lung Disease [<a href="#rid6">6</a>]. The roadmap calls for a multidisciplinary "One Health" approach that includes improved diagnosis and surveillance and reduced transmission between animals and humans.</p><p>Immunization with Bacillus Calmette-Guérin and treatment of latent infection are likely to be effective for prevention of <em>M. bovis</em> as <em>M. tuberculosis</em>; further study is needed. Infection control precautions for <em>M. bovis</em> should be followed as for <em>M. tuberculosis </em>[<a href="#rid44">44</a>]. (See  <a class="medical medical_review" href="/d/html/8000.html" rel="external">"Tuberculosis transmission and control in health care settings"</a>.)</p><p class="headingAnchor" id="H26587936"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><em>Mycobacterium bovis</em> is a member of the <em>Mycobacterium tuberculosis</em> complex (MTBC), which also includes <em>M. tuberculosis</em>. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In resource-limited settings, minimal data are available regarding the relative frequency of disease due to <em>M. bovis</em> because of limited laboratory facilities for culture and identification. In developed countries, approximately 1 to 2 percent of human tuberculosis cases are attributable to <em>M. bovis</em>; some settings have higher proportions such as the San Diego, California region, where the proportion of culture-positive tuberculosis cases attributed to <em>M. bovis</em> increased from 3 to 11 percent between 1980 and 2005. (See <a class="local">'Epidemiology and risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Risk factors for <em>M. bovis</em> infection include consumption of unpasteurized dairy products and contact with infected animals or humans. Among patients diagnosed with tuberculosis, the possibility of <em>M. bovis</em> infection should be considered in the setting of Hispanic ethnicity, age &lt;15 years, immunosuppression, HIV infection, and extrapulmonary disease. (See <a class="local">'Risk factors'</a> above and <a class="local">'Transmission'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tuberculosis due to <em>M. bovis</em> is clinically and radiographically indistinguishable from tuberculosis due to <em>M. tuberculosis</em>. Like <em>M. tuberculosis</em>, <em>M. bovis</em> can manifest with primary and reactivation forms; involvement may be pulmonary, extrapulmonary, or disseminated. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Establishing a diagnosis of <em>M. bovis</em> is challenging because many laboratories in tuberculosis-endemic settings do not distinguish among members of the MTBC. <em>M. bovis</em> infection should be considered in the setting of an MTBC isolate with <a class="drug drug_general" data-topicid="9836" href="/d/drug information/9836.html" rel="external">pyrazinamide</a> (PZA) monoresistance. State public health laboratories can assist with definitive identification. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with disease due to drug-susceptib<em>le M. bovis</em>, we recommend treatment with two months of daily <a class="drug drug_general" data-topicid="8577" href="/d/drug information/8577.html" rel="external">isoniazid</a>, <a class="drug drug_general" data-topicid="9864" href="/d/drug information/9864.html" rel="external">rifampin</a>, and <a class="drug drug_general" data-topicid="9430" href="/d/drug information/9430.html" rel="external">ethambutol</a>, followed by seven months of isoniazid and rifampin (daily or twice weekly) (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>). Susceptibility testing and expert consultation should guide individualized therapy for polyresista<em>nt M. bovis</em>. (See <a class="local">'Treatment'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Grange JM, Yates MD, de Kantor IN. Guidelines for speciation within the Mycobacterium tuberculosis complex, 2nd ed, WHO/EMC/ZOO/96.4.</li><li><a class="nounderline abstract_t">Comas I, Coscolla M, Luo T, et al. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat Genet 2013; 45:1176.</a></li><li><a class="nounderline abstract_t">Garnier T, Eiglmeier K, Camus JC, et al. The complete genome sequence of Mycobacterium bovis. Proc Natl Acad Sci U S A 2003; 100:7877.</a></li><li><a class="nounderline abstract_t">Kohl TA, Kranzer K, Andres S, et al. Population Structure of Mycobacterium bovis in Germany: a Long-Term Study Using Whole-Genome Sequencing Combined with Conventional Molecular Typing Methods. J Clin Microbiol 2020; 58.</a></li><li><a class="nounderline abstract_t">Olea-Popelka F, Muwonge A, Perera A, et al. Zoonotic tuberculosis in human beings caused by Mycobacterium bovis-a call for action. Lancet Infect Dis 2017; 17:e21.</a></li><li class="breakAll">World Health Organization, Global tuberculosis report 2021. https://www.who.int/tb/publications/global_report/en/ (Accessed on November 08, 2021).</li><li><a class="nounderline abstract_t">Kanipe C, Palmer MV. Mycobacterium bovis and you: A comprehensive look at the bacteria, its similarities to Mycobacterium tuberculosis, and its relationship with human disease. Tuberculosis (Edinb) 2020; 125:102006.</a></li><li class="breakAll">Health Protection Agency. Tuberculosis in the UK: Annual report on tuberculosis surveillance in the UK:2008. HPA, London, United Kingdom.</li><li><a class="nounderline abstract_t">Mandal S, Bradshaw L, Anderson LF, et al. Investigating transmission of Mycobacterium bovis in the United Kingdom in 2005 to 2008. J Clin Microbiol 2011; 49:1943.</a></li><li><a class="nounderline abstract_t">Esteban J, Robles P, Soledad Jiménez M, Fernández Guerrero ML. Pleuropulmonary infections caused by Mycobacterium bovis: a re-emerging disease. Clin Microbiol Infect 2005; 11:840.</a></li><li><a class="nounderline abstract_t">Dupon M, Ragnaud JM. Tuberculosis in patients infected with human immunodeficiency virus 1. A retrospective multicentre study of 123 cases in France. The Groupe des Infectiologues du Sud de la France. Q J Med 1992; 85:719.</a></li><li><a class="nounderline abstract_t">Müller B, Dürr S, Alonso S, et al. Zoonotic Mycobacterium bovis-induced tuberculosis in humans. Emerg Infect Dis 2013; 19:899.</a></li><li><a class="nounderline abstract_t">Bobadilla-del Valle M, Torres-González P, Cervera-Hernández ME, et al. Trends of Mycobacterium bovis Isolation and First-Line Anti-tuberculosis Drug Susceptibility Profile: A Fifteen-Year Laboratory-Based Surveillance. PLoS Negl Trop Dis 2015; 9:e0004124.</a></li><li><a class="nounderline abstract_t">Cadmus S, Akinseye VO, van Soolingen D. Mycobacterium bovis in humans and M. tuberculosis in animals in Nigeria: an overview from 1975-2014. Int J Tuberc Lung Dis 2019; 23:1162.</a></li><li><a class="nounderline abstract_t">Getahun M, Blumberg HM, Sinshaw W, et al. Low Prevalence of Mycobacterium bovis in Tuberculosis Patients, Ethiopia. Emerg Infect Dis 2020; 26:613.</a></li><li><a class="nounderline abstract_t">Chen Y, Chao Y, Deng Q, et al. Potential challenges to the Stop TB Plan for humans in China; cattle maintain M. bovis and M. tuberculosis. Tuberculosis (Edinb) 2009; 89:95.</a></li><li><a class="nounderline abstract_t">Jiang G, Wang G, Chen S, et al. Pulmonary tuberculosis caused by Mycobacterium bovis in China. Sci Rep 2015; 5:8538.</a></li><li><a class="nounderline abstract_t">Scott C, Cavanaugh JS, Pratt R, et al. Human Tuberculosis Caused by Mycobacterium bovis in the United States, 2006-2013. Clin Infect Dis 2016; 63:594.</a></li><li><a class="nounderline abstract_t">Rodwell TC, Moore M, Moser KS, et al. Tuberculosis from Mycobacterium bovis in binational communities, United States. Emerg Infect Dis 2008; 14:909.</a></li><li><a class="nounderline abstract_t">Park D, Qin H, Jain S, et al. Tuberculosis due to Mycobacterium bovis in patients coinfected with human immunodeficiency virus. Clin Infect Dis 2010; 51:1343.</a></li><li><a class="nounderline abstract_t">Gallivan M, Shah N, Flood J. Epidemiology of human Mycobacterium bovis disease, California, USA, 2003-2011. Emerg Infect Dis 2015; 21:435.</a></li><li><a class="nounderline abstract_t">Cordova E, Gonzalo X, Boschi A, et al. Human Mycobacterium bovis infection in Buenos Aires: epidemiology, microbiology and clinical presentation. Int J Tuberc Lung Dis 2012; 16:415.</a></li><li><a class="nounderline abstract_t">Vayr F, Martin-Blondel G, Savall F, et al. Occupational exposure to human Mycobacterium bovis infection: A systematic review. PLoS Negl Trop Dis 2018; 12:e0006208.</a></li><li><a class="nounderline abstract_t">Majoor CJ, Magis-Escurra C, van Ingen J, et al. Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993-2007. Emerg Infect Dis 2011; 17:457.</a></li><li><a class="nounderline abstract_t">Portillo-Gómez L, Sosa-Iglesias EG. Molecular identification of Mycobacterium bovis and the importance of zoonotic tuberculosis in Mexican patients. Int J Tuberc Lung Dis 2011; 15:1409.</a></li><li><a class="nounderline abstract_t">Kurbatova EV, Cavanaugh JS, Dalton T, et al. Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999-2009. Clin Infect Dis 2013; 57:1081.</a></li><li><a class="nounderline abstract_t">Hlavsa MC, Moonan PK, Cowan LS, et al. Human tuberculosis due to Mycobacterium bovis in the United States, 1995-2005. Clin Infect Dis 2008; 47:168.</a></li><li><a class="nounderline abstract_t">Lombardi G, Botti I, Pacciarini ML, et al. Five-year surveillance of human tuberculosis caused by Mycobacterium bovis in Bologna, Italy: an underestimated problem. Epidemiol Infect 2017; 145:3035.</a></li><li><a class="nounderline abstract_t">Torres-Gonzalez P, Cervera-Hernandez ME, Martinez-Gamboa A, et al. Human tuberculosis caused by Mycobacterium bovis: a retrospective comparison with Mycobacterium tuberculosis in a Mexican tertiary care centre, 2000-2015. BMC Infect Dis 2016; 16:657.</a></li><li><a class="nounderline abstract_t">Higgitt RL, Louis van Schalkwyk O, de Klerk-Lorist LM, et al. Mycobacterium bovis Infection in African Wild Dogs, Kruger National Park, South Africa. Emerg Infect Dis 2019; 25:1425.</a></li><li><a class="nounderline abstract_t">Torres-Gonzalez P, Soberanis-Ramos O, Martinez-Gamboa A, et al. Prevalence of latent and active tuberculosis among dairy farm workers exposed to cattle infected by Mycobacterium bovis. PLoS Negl Trop Dis 2013; 7:e2177.</a></li><li><a class="nounderline abstract_t">Adesokan HK, Jenkins AO, van Soolingen D, Cadmus SI. Mycobacterium bovis infection in livestock workers in Ibadan, Nigeria: evidence of occupational exposure. Int J Tuberc Lung Dis 2012; 16:1388.</a></li><li><a class="nounderline abstract_t">Sanou A, Tarnagda Z, Kanyala E, et al. Mycobacterium bovis in Burkina Faso: epidemiologic and genetic links between human and cattle isolates. PLoS Negl Trop Dis 2014; 8:e3142.</a></li><li><a class="nounderline abstract_t">Fanning A, Edwards S. Mycobacterium bovis infection in human beings in contact with elk (Cervus elaphus) in Alberta, Canada. Lancet 1991; 338:1253.</a></li><li><a class="nounderline abstract_t">Wilkins MJ, Meyerson J, Bartlett PC, et al. Human Mycobacterium bovis infection and bovine tuberculosis outbreak, Michigan, 1994-2007. Emerg Infect Dis 2008; 14:657.</a></li><li><a class="nounderline abstract_t">Sunstrum J, Shoyinka A, Power LE, et al. Notes from the Field: Zoonotic Mycobacterium bovis Disease in Deer Hunters - Michigan, 2002-2017. MMWR Morb Mortal Wkly Rep 2019; 68:807.</a></li><li><a class="nounderline abstract_t">O'Connor CM, Abid M, Walsh AL, et al. Cat-to-Human Transmission of Mycobacterium bovis, United Kingdom. Emerg Infect Dis 2019; 25:2284.</a></li><li><a class="nounderline abstract_t">LoBue PA, Betancourt W, Cowan L, et al. Identification of a familial cluster of pulmonary Mycobacterium bovis disease. Int J Tuberc Lung Dis 2004; 8:1142.</a></li><li><a class="nounderline abstract_t">Velayati AA, Farnia P, Boloorsaze MR, et al. Mycobacterium bovis infection in children in the same family: transmission through inhalation. Monaldi Arch Chest Dis 2007; 67:169.</a></li><li><a class="nounderline abstract_t">Evans JT, Smith EG, Banerjee A, et al. Cluster of human tuberculosis caused by Mycobacterium bovis: evidence for person-to-person transmission in the UK. Lancet 2007; 369:1270.</a></li><li><a class="nounderline abstract_t">Akkerman O, van der Loo K, Nijmeijer D, et al. Mycobacterium bovis infection in a young Dutch adult: transmission from an elderly human source? Med Microbiol Immunol 2012; 201:397.</a></li><li><a class="nounderline abstract_t">Buss BF, Keyser-Metobo A, Rother J, et al. Possible Airborne Person-to-Person Transmission of Mycobacterium bovis - Nebraska 2014-2015. MMWR Morb Mortal Wkly Rep 2016; 65:197.</a></li><li><a class="nounderline abstract_t">Rullán JV, Herrera D, Cano R, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in Spain. Emerg Infect Dis 1996; 2:125.</a></li><li><a class="nounderline abstract_t">Rivero A, Márquez M, Santos J, et al. High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B. Clin Infect Dis 2001; 32:159.</a></li><li><a class="nounderline abstract_t">Bouvet E, Casalino E, Mendoza-Sassi G, et al. A nosocomial outbreak of multidrug-resistant Mycobacterium bovis among HIV-infected patients. A case-control study. AIDS 1993; 7:1453.</a></li><li><a class="nounderline abstract_t">Guerrero A, Cobo J, Fortún J, et al. Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection. Lancet 1997; 350:1738.</a></li><li><a class="nounderline abstract_t">Ramdas KE, Lyashchenko KP, Greenwald R, et al. Mycobacterium bovis infection in humans and cats in same household, Texas, USA, 2012. Emerg Infect Dis 2015; 21:480.</a></li><li><a class="nounderline abstract_t">Vazquez-Chacon CA, Martínez-Guarneros A, Couvin D, et al. Human multidrug-resistant Mycobacterium bovis infection in Mexico. Tuberculosis (Edinb) 2015; 95:802.</a></li><li><a class="nounderline abstract_t">Sagasti S, Millán-Lou MI, Soledad Jiménez M, et al. In-depth analysis of the genome sequence of a clinical, extensively drug-resistant Mycobacterium bovis strain. Tuberculosis (Edinb) 2016; 100:46.</a></li><li><a class="nounderline abstract_t">Vázquez-Chacón CA, Rodríguez-Gaxiola FJ, López-Carrera CF, et al. Identification of drug resistance mutations among Mycobacterium bovis lineages in the Americas. PLoS Negl Trop Dis 2021; 15:e0009145.</a></li><li><a class="nounderline abstract_t">Kasambira TS, Alwood K, Baker J, et al. Lymphadenitis in an 18-month-old traveler to Mexico. Pediatr Infect Dis J 2007; 26:968, 973.</a></li><li><a class="nounderline abstract_t">Cachafeiro-Vilar A, García-Padilla C, Reyes E, Hernández-Molina G. Polyarticular arthritis secondary to Mycobacterium bovis infection: an unusual clinical presentation. Joint Bone Spine 2007; 74:107.</a></li><li><a class="nounderline abstract_t">Valença-Filipe R, Costa J, Martins A. Mycobacterium bovis: a rare cause of hand tenosynovitis. J Hand Surg Eur Vol 2014; 39:780.</a></li><li><a class="nounderline abstract_t">Liesegang TJ, Cameron JD. Mycobacterium bovis infection of the conjunctiva. Arch Ophthalmol 1980; 98:1764.</a></li><li><a class="nounderline abstract_t">González-Duarte A, Ponce de León A, Osornio JS. Importance of differentiating Mycobaterium bovis in tuberculous meningitis. Neurol Int 2011; 3:e9.</a></li><li><a class="nounderline abstract_t">Modrego-Pardo PJ. [Uncommon case of Mycobacterium bovis brain abscess complicated by suppurative fistula]. Rev Neurol 2020; 70:270.</a></li><li><a class="nounderline abstract_t">Pemartín B, Portolés Morales M, Elena Carazo M, et al. Mycobacterium Bovis Abdominal Tuberculosis in a Young Child. Pediatr Infect Dis J 2015; 34:1133.</a></li><li><a class="nounderline abstract_t">Anantha RV, Salvadori MI, Hussein MH, Merritt N. Abdominal cocoon syndrome caused by Mycobacterium bovis from consumption of unpasteurised cow's milk. Lancet Infect Dis 2015; 15:1498.</a></li><li><a class="nounderline abstract_t">Ghariani A, Jaouadi T, Smaoui S, et al. Diagnosis of lymph node tuberculosis using the GeneXpert MTB/RIF in Tunisia. Int J Mycobacteriol 2015; 4:270.</a></li><li><a class="nounderline abstract_t">Pong A, Moser KS, Park SM, et al. Evaluation of an Interferon Gamma Release Assay to Detect Tuberculosis Infection in Children in San Diego, California. J Pediatric Infect Dis Soc 2012; 1:74.</a></li><li class="breakAll">United States Centers for Disease Control and Prevention. Tuberculosis Genotyping in the United States, 2004–2010. United States Department of Health and Human Services. Atlanta, GA, June 2012. https://www.cdc.gov/tb/programs/genotyping/GenotypingReport.pdf (Accessed on October 09, 2018).</li><li><a class="nounderline abstract_t">LoBue PA, Moser KS. Treatment of Mycobacterium bovis infected tuberculosis patients: San Diego County, California, United States, 1994-2003. Int J Tuberc Lung Dis 2005; 9:333.</a></li><li><a class="nounderline abstract_t">Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis 2016; 63:e147.</a></li><li><a class="nounderline abstract_t">Lan Z, Bastos M, Menzies D. Treatment of human disease due to Mycobacterium bovis: a systematic review. Eur Respir J 2016; 48:1500.</a></li><li><a class="nounderline abstract_t">Scott C, Cavanaugh JS, Silk BJ, et al. Comparison of Sputum-Culture Conversion for Mycobacterium bovis and M. tuberculosis. Emerg Infect Dis 2017; 23:456.</a></li></ol></div><div id="topicVersionRevision">Topic 8006 Version 22.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Grange JM, Yates MD, de Kantor IN. Guidelines for speciation within the Mycobacterium tuberculosis complex, 2nd ed, WHO/EMC/ZOO/96.4.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23995134" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12788972" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The complete genome sequence of Mycobacterium bovis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32817084" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Population Structure of Mycobacterium bovis in Germany: a Long-Term Study Using Whole-Genome Sequencing Combined with Conventional Molecular Typing Methods.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27697390" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Zoonotic tuberculosis in human beings caused by Mycobacterium bovis-a call for action.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27697390" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Zoonotic tuberculosis in human beings caused by Mycobacterium bovis-a call for action.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33032093" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Mycobacterium bovis and you: A comprehensive look at the bacteria, its similarities to Mycobacterium tuberculosis, and its relationship with human disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33032093" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Mycobacterium bovis and you: A comprehensive look at the bacteria, its similarities to Mycobacterium tuberculosis, and its relationship with human disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21430093" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Investigating transmission of Mycobacterium bovis in the United Kingdom in 2005 to 2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16153260" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Pleuropulmonary infections caused by Mycobacterium bovis: a re-emerging disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1287704" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Tuberculosis in patients infected with human immunodeficiency virus 1. A retrospective multicentre study of 123 cases in France. The Groupe des Infectiologues du Sud de la France.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23735540" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Zoonotic Mycobacterium bovis-induced tuberculosis in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26421930" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Trends of Mycobacterium bovis Isolation and First-Line Anti-tuberculosis Drug Susceptibility Profile: A Fifteen-Year Laboratory-Based Surveillance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31718752" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Mycobacterium bovis in humans and M. tuberculosis in animals in Nigeria: an overview from 1975-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32091379" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Low Prevalence of Mycobacterium bovis in Tuberculosis Patients, Ethiopia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19056318" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Potential challenges to the Stop TB Plan for humans in China; cattle maintain M. bovis and M. tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25736338" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Pulmonary tuberculosis caused by Mycobacterium bovis in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27298329" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Human Tuberculosis Caused by Mycobacterium bovis in the United States, 2006-2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18507901" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Tuberculosis from Mycobacterium bovis in binational communities, United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21028986" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Tuberculosis due to Mycobacterium bovis in patients coinfected with human immunodeficiency virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25693687" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Epidemiology of human Mycobacterium bovis disease, California, USA, 2003-2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22230360" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Human Mycobacterium bovis infection in Buenos Aires: epidemiology, microbiology and clinical presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29337996" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Occupational exposure to human Mycobacterium bovis infection: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21392437" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993-2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22283903" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Molecular identification of Mycobacterium bovis and the importance of zoonotic tuberculosis in Mexican patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23840002" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999-2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18532886" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Human tuberculosis due to Mycobacterium bovis in the United States, 1995-2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28879829" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Five-year surveillance of human tuberculosis caused by Mycobacterium bovis in Bologna, Italy: an underestimated problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27825312" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Human tuberculosis caused by Mycobacterium bovis: a retrospective comparison with Mycobacterium tuberculosis in a Mexican tertiary care centre, 2000-2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31211936" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Mycobacterium bovis Infection in African Wild Dogs, Kruger National Park, South Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23638198" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Prevalence of latent and active tuberculosis among dairy farm workers exposed to cattle infected by Mycobacterium bovis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22863763" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Mycobacterium bovis infection in livestock workers in Ibadan, Nigeria: evidence of occupational exposure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25275305" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Mycobacterium bovis in Burkina Faso: epidemiologic and genetic links between human and cattle isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1682654" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Mycobacterium bovis infection in human beings in contact with elk (Cervus elaphus) in Alberta, Canada.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18394288" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Human Mycobacterium bovis infection and bovine tuberculosis outbreak, Michigan, 1994-2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31536485" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Notes from the Field: Zoonotic Mycobacterium bovis Disease in Deer Hunters - Michigan, 2002-2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31742516" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Cat-to-Human Transmission of Mycobacterium bovis, United Kingdom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15455603" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Identification of a familial cluster of pulmonary Mycobacterium bovis disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18027492" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Mycobacterium bovis infection in children in the same family: transmission through inhalation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17434402" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Cluster of human tuberculosis caused by Mycobacterium bovis: evidence for person-to-person transmission in the UK.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22426821" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Mycobacterium bovis infection in a young Dutch adult: transmission from an elderly human source?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26938831" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Possible Airborne Person-to-Person Transmission of Mycobacterium bovis - Nebraska 2014-2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8903213" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in Spain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11112675" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8280411" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : A nosocomial outbreak of multidrug-resistant Mycobacterium bovis among HIV-infected patients. A case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9413465" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25695666" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Mycobacterium bovis infection in humans and cats in same household, Texas, USA, 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26299906" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Human multidrug-resistant Mycobacterium bovis infection in Mexico.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27553409" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : In-depth analysis of the genome sequence of a clinical, extensively drug-resistant Mycobacterium bovis strain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33591982" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Identification of drug resistance mutations among Mycobacterium bovis lineages in the Americas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17901811" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Lymphadenitis in an 18-month-old traveler to Mexico.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17196422" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Polyarticular arthritis secondary to Mycobacterium bovis infection: an unusual clinical presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23340760" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Mycobacterium bovis: a rare cause of hand tenosynovitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7000052" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Mycobacterium bovis infection of the conjunctiva.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22368776" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Importance of differentiating Mycobaterium bovis in tuberculous meningitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32182377" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : [Uncommon case of Mycobacterium bovis brain abscess complicated by suppurative fistula].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26132823" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Mycobacterium Bovis Abdominal Tuberculosis in a Young Child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26607132" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Abdominal cocoon syndrome caused by Mycobacterium bovis from consumption of unpasteurised cow's milk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26964807" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Diagnosis of lymph node tuberculosis using the GeneXpert MTB/RIF in Tunisia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26618694" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Evaluation of an Interferon Gamma Release Assay to Detect Tuberculosis Infection in Children in San Diego, California.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26618694" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Evaluation of an Interferon Gamma Release Assay to Detect Tuberculosis Infection in Children in San Diego, California.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15786900" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Treatment of Mycobacterium bovis infected tuberculosis patients: San Diego County, California, United States, 1994-2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27516382" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27540021" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Treatment of human disease due to Mycobacterium bovis: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28221125" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Comparison of Sputum-Culture Conversion for Mycobacterium bovis and M. tuberculosis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
